Market Pulse · Daily Scan
Daily Market Pulse
Jul 16, 2026 · sentiment/flow window ≈ 48h · Track A reflects the 48h window ending at the Jul 16 2026 close (Thu). The window spans the Jul 15 (Wed) and Jul 16 (Thu) sessions. Jul 16 was dominated by a 4th straight day of semiconductor/memory selling (SOX -~4%) triggered by TSMC's Q2 capex hike and AI-monetization/ROI doubts, against a rotation into healthcare, financials, and payments on Q2 earnings. DEEP_DIVE_WATCHLIST was not supplied to this run, so no name could be organically matched against a deep-dive library; all in_deep_dive_library flags are set false by necessity, not by scan result.
Pre-marketnot publishedPost-market
TLDR;
Cautiously constructive but rotational, NOT risk-off. Beneath a -0.51% S&P 500 and -1.47% Nasdaq Composite sits genuinely healthy breadth (~75% of S&P names higher, 10 of 11 sectors green, small-caps positive) — the red headline is almost entirely a cap-weighted semiconductor/memory drag (Philadelphia SOX -~4%, Micron -~6%, TSM lower despite a record beat) on renewed AI-capex angst after TSMC raised 2026 capex to $60-64B plus a ~$100B Arizona commitment. Macro was supportive: in-line June retail sales (+0.2%), sub-consensus weekly jobless claims (208K), and a blowout Philly Fed (41.4). The 10Y held ~4.56% and WTI eased to ~$79.5. VIX ticked up to ~16.7 (+~7%) but remains low, signaling orderly rotation (tech -> healthcare/financials/defensives) rather than broad de-risking; US-Iran tension is the main tail keeping a floor under crude. Breadth: Broad advance masked by cap-weighted chip drag: ~75% of S&P 500 constituents closed higher and 10 of 11 sectors rose, yet the cap-weighted indices fell on a ~4% semiconductor decline. Leaders: Health Care (UNH earnings), Financials/asset managers. Laggards: Technology/Semiconductors (SOX -~4%)..A · Daily Pulse
What moved — and why
▲ Rising — dailycomposite
| # | Ticker | Move | Driver | Score |
|---|---|---|---|---|
| 1 | ABT | +11% | Q2 beat-and-raise: revenue $12.6B (+13% reported), adj EPS $1.31; raised FY adj EPS to $5.45-$5.60. Diagnostics +42% (Exact Sciences), Medical Devices +9% (electrophysiology); Nutrition -3.1% the soft spot. Magnitude conflicts across sources (+10% TheStreet vs +12.5% Motley Fool); direction certain. | 73 |
| 2 | PYPL | +17.2% | Largest S&P gainer of the day at +17.2% (Trefis). A move this size in a name this large is almost certainly an earnings/guidance or corporate-action event, but the specific catalyst could NOT be verified this pass. Verified move, UNVERIFIED catalyst — data gap to close, not confirmed hype. NOTE: on the prior run (Jul 15) PYPL rose ~16% on a Stripe/Advent takeover bid; today's driver is unconfirmed and may be a continuation or a separate catalyst. unverified | 70 |
| 3 | UNH | +3.6% | Clean Q2 beat-and-raise: adj EPS ~$6.38 (+56% y/y), revenue ~$112B; medical-care ratio improved to ~86.7% (from ~89.4% y/y); FY26 adj EPS guide raised to $19.50-$20.00 vs ~$18.48 consensus. Analysts lifted PTs (e.g., Baird $287->$453). MAGNITUDE CONFLICT: GuruFocus/close recap +3.6% vs an intraday snapshot (~+8%); used the more conservative sourced close. Same name is a Track B downside — thesis materially weakened by this print. | 68 |
| 4 | BLK | +6.6% | Among the day's top gainers (+6.6%, Trefis); part of an asset-manager cohort that rallied (IVZ, BNY). Consistent with Q2 results/AUM strength but the specific catalyst was not verified this pass. unverified | 58 |
| 5 | USB | +1.33% | Q2 beat: adj EPS $1.35 vs $1.28 est (+22% y/y), record net revenue $7.71B, NIM 2.79% vs 2.66%; raised FY revenue outlook to $30.71-$31.28B. Closed +1.33% at ~$63.85. | 58 |
| 6 | BNY | +5.1% | Rose +5.1% (Trefis) within the asset-manager/trust-bank cohort; likely Q2 bank earnings but the specific print was not verified this pass. unverified | 56 |
| 7 | AAPL | — | Cited as trading at record highs during the session (Yahoo live blog); a megacap-tech pocket of strength against the semiconductor drag. Exact % UNVERIFIED — included as directional only. | 56 |
| 8 | CBRE | +6.2% | Named among the day's top gainers (+6.2%, Trefis); no single confirmed catalyst itemized (possible rate-relief/real-estate rotation). Verified move, UNVERIFIED catalyst. unverified | 55 |
| 9 | IVZ | +5.5% | Up +5.5% (Trefis) alongside the asset-manager cohort; catalyst UNVERIFIED. Market cap is near the $10B line and should be re-verified before inclusion. unverified | 54 |
▼ Falling — dailycomposite
| # | Ticker | Move | Driver | Score |
|---|---|---|---|---|
| 1 | MU | −6.2% | Center of a 4th straight day of memory-sector selling. TSMC raising 2026 capex to $60-64B (from $52-56B) plus a ~$100B Arizona commitment stoked oversupply / AI-capex-ROI fears; SK Hynix -9.1% on the same theme. Magnitude conflict ~-6% (TheStreet) vs -6.3% (Motley Fool); direction certain. Same name is a Track B upside (super-cycle) — legitimately appears in both tracks with opposite sign. | 70 |
| 2 | DELL | −9.8% | Fell -9.8% (Trefis); best-inferred driver is the AI-hardware/memory-cost selloff (rising memory input costs pressure server/PC margins) rather than a verified single-stock catalyst. | 62 |
| 3 | GOOGL | −4.4% | Fell on AI-capex anxiety across hyperscalers plus DOJ/regulatory overhang and Gemini/competition concerns, into its Jul 22 earnings. Magnitude conflict: -3.85% (TradingKey) vs -4.43% (Yahoo close wrap); an early live-blog +3.6% was a premarket/futures snapshot contradicted by the close. A separate 'Alphabet -6%' article was dated Jun 22 and discarded. | 61 |
| 4 | GE | −4% | Beat-and-raise (Q2 adj EPS $2.02 vs $1.86 est, revenue +21%, FY adj EPS raised to $7.65-$7.85) but fell ~-4% — classic 'sell-the-news' on elevated expectations and signs of moderating order growth. | 60 |
| 5 | PNR | −15% | Largest S&P decliner at -15.0% (Trefis). A drop this size strongly implies an earnings miss / guidance cut, but the specific catalyst was not verified this pass. Verified move, UNVERIFIED catalyst. unverified | 59 |
| 6 | WDC | −8.8% | Down -8.8% (Trefis) with the memory/storage complex (MU, SK Hynix) on the TSMC-capex oversupply scare. Sector-driven, not a company-specific catalyst. | 59 |
| 7 | PGR | −9.4% | Down -9.4% (Trefis); insurer, likely a Q2 margin/results reaction but the specific print was not verified this pass. unverified | 58 |
| 8 | AVGO | −3.6% | Down -3.6% (Motley Fool) in the broad semiconductor de-rating / AI-capex-ROI rotation. Sector-driven. Same name is a Track B upside on the 12-month view. | 57 |
| 9 | ERIE | −11.9% | Down -11.9% (Trefis); catalyst UNVERIFIED (magnitude implies an earnings/estimate disappointment). Verified move, UNVERIFIED catalyst. unverified | 56 |
| 10 | NVDA | −2.7% | Down -2.7% (Motley Fool) with the chip complex on AI-capex-ROI angst. Sector rotation, not a company catalyst. Same name is the #1 Track B upside on the 12-month view. | 56 |
B · One-Year Conviction
Asymmetric 12-month skew
Free sources only. Market caps are stockanalysis.com dated Jul 16 2026 snapshots unless noted. Estimate-revision 'direction' is inferred from analyst PT/rating actions, Zacks ranks, and consensus-move notes, not full institutional revision breadth (paywalled). Directional, not precise. Not financial advice. Material change this run: UNH beat-and-raised on Jul 16 and its short thesis is materially weakened (demoted to the bottom downside slot); MRVL's short thesis strengthened on a -8-9% AI-capex-slowdown day.
▲ Upside skew — 1yrconviction
| Ticker | Thesis | Key risk | Score |
|---|---|---|---|
| NVDA | AI-compute leader; consensus Strong Buy, avg PT ~$302 (KeyBanc $310->$330 Jul 14). Vera Rubin ramp into 2H26; ~50% of revenue now non-hyperscaler. TSMC's Jul 16 capex raise confirms the hyperscaler buildout has not peaked despite the day's 'AI-ceiling' selloff. | AI-capex digestion / hyperscaler capex pause; rotation from pure-play semis to other AI-infra layers; valuation | 82 |
| TSM | Advanced-node foundry monopoly. Jul 16 Q2: record revenue ~$40.2B (+~36% y/y), gross margin 67.7%, Q3 guide +~37%; capex raised to $60-64B and Arizona commitment lifted to ~$100B (~$265B total). Barclays $470->$625, Susquehanna $575->$600. Beat-and-raise reinforces the whole AI-infra chain — even though the ADR dipped on capex-intensity fears the same day. | Taiwan geopolitics; capex-cycle intensity compressing FCF; cyclicality | 81 |
| AVGO | Custom AI accelerators (XPU) + networking. Positive revisions (JPM $500->$580, BofA $450->$530). Record AI-semi revenue growth; networking a large share of AI revenue. Same name is a Track A faller today on sector rotation — the 12-month thesis is intact. | rotation out of semis; XPU revenue concentrated in a few hyperscaler customers; valuation | 75 |
| CEG | Nuclear power for AI data centers. Buy consensus, PT ~$358 (~43% implied upside). Catalysts: Walmart nuclear PPA (Jun 23), Calpine deal closed, prior Microsoft/Meta data-center deals. Structural power-scarcity long. | power-price/regulatory; data-center demand normalization; valuation | 71 |
| MU | HBM/AI-memory super-cycle; Strong Buy revisions (KeyBanc $1,600->$1,750 Jul 14, sourced PT ~$1,486). NOTE: same name is a Track A faller today (memory-sector drag) — legitimately in both tracks. Heightened parabolic-reversal caveat after a ~6x run. | memory/DRAM/HBM pricing cyclicality and 2027 oversupply risk (amplified by TSMC's capex raise); parabolic-reversal / momentum risk; valuation | 69 |
| AMAT | Wafer-fab-equipment beneficiary of next-gen AI chips, DRAM, and advanced packaging into 2H26 (Needham $530->$740). Upside now modest — price sits near consensus PT (~$606), so it is revision-dependent. | WFE cyclicality; China export controls; trades near PT — limited margin of safety | 68 |
| BWXT | Nuclear-component + SMR play. Deutsche upgraded Hold->Buy ($205->$255); record backlog ~$8.65B; positive drift on government/commercial nuclear demand. Power-scarcity structural long. | federal-budget dependence; SMR timeline slippage; valuation | 66 |
| MPWR | Power management for AI servers; Moderate Buy, PT ~$1,599 (KeyCorp $1,500->$2,000). Enterprise-data revenue growing rapidly. Reports Jul 30 (inside the wider catalyst horizon). | NVIDIA-platform concentration; high valuation; cyclicality | 65 |
| GEV | Grid/power equipment + SMR (GE-Hitachi BWRX-300) levered to AI-driven electricity demand. WEAKENING vs baseline: Jefferies cut $1,350->$1,210, Zacks moved to Hold, PT ~$1,090 only ~5% above price. Reports Jul 22 (binary event inside the horizon). Candidate for demotion next full run. | trades ~at consensus PT; mixed/flattening revisions; Jul 22 earnings is binary; project execution | 62 |
| CSCO | AI-era networking (NVIDIA partner); BofA $135->$150, Zacks Hold->Strong Buy. Slower-growth, lower-multiple way to play AI infrastructure; upside modest after re-rating (PT ~$123, ~13% up). Reports ~Aug 12. | slower structural growth vs pure-play AI names; competitive networking pressure; limited upside to PT | 61 |
▼ Downside skew — 1yrconviction
| Ticker | Thesis | Key risk | Score |
|---|---|---|---|
| TSLA | Margin quality vs a robotaxi-priced multiple. Analyst split (of ~47: ~19 Hold, ~6 Sell; PT ~$425); four straight quarterly misses. Q2 deliveries known (~480k, +25%); the Jul 22 AMC print is about margins, not volume. Binary into that event. | robotaxi/FSD monetization inflects and justifies the multiple; auto margins reaccelerate; Jul 22 earnings is a binary event | 66 |
| CRWV | Debt-funded, customer-concentrated AI buildout — 'poster child of the AI-infrastructure bubble'. >7x leverage; 5 straight down days; sell-side PTs (avg ~$141) appear to lag a price collapse to ~$73. Strengthened by the Jul 16 AI-capex-ROI scare. | durable contracted AI capacity demand + successful debt refinancing invalidate the bear case; Meta/anchor-customer concentration resolves favorably | 63 |
| MRVL | AWS custom-silicon concentration risk into a still-priced-for-growth multiple. Benchmark Buy->Hold; fell ~8-9% on Jul 16 in the AI-capex-slowdown selloff — the freshest confirming catalyst among the semi shorts. (Ranked by composite; note this is the highest-conviction NEW short catalyst this run.) | AWS re-award or custom-silicon diversification; AI-ASIC demand stays strong; sell-side PTs still ~$253 (bullish) — contested | 62 |
| PLTR | Pure valuation-compression short (P/S ~62, P/E ~151) against strong growth. Consensus PTs are bullish (~$183, ~+38%), so this is contrarian and needs a de-rating catalyst; lowest-conviction of the downside names. retail-heavy | sustained 50%+ revenue compounding justifies the premium multiple; crowded/retail-heavy — squeeze risk | 59 |
| DE | Ag downcycle + tariff drag. FY26 net-income guide cut to $4.0-4.75B (down y/y); ~$1.2B tariff headwind; PT ~$648 only ~8% above price. Reports ~Aug 20. | 2027 replacement-demand snapback off 17-yr-low fleet age; trade normalization; ag-cycle trough reverses the earnings decline | 59 |
| DKNG | Structural share erosion to CFTC-regulated prediction markets (Kalshi, Polymarket). PTs cut broadly (Moffett $38->$27, Buy->Neutral; BNP rare Sell). Reports Aug 6. | regulatory clampdown on prediction markets; DKNG handle/margin reacceleration; mcap near threshold | 57 |
| UNH | DEMOTED. Jul 16 Q2 beat-and-raise (adj EPS ~$6.38, medical-care ratio improved to ~86.7%, FY guide raised to $19.50-$20.00) materially weakened the short; revisions turned UP (Baird $287->$453). Only the unresolved DOJ Medicare-Advantage probe (status UNVERIFIED beyond 'still open') keeps a residual bear case. Also a Track A riser today. | margin normalization continues (bull case now confirming); benign DOJ resolution removes the last leg; consensus is Buy again | 51 |
C · Options Heat
Where the premium is paying up
| Ticker | Signal | Read | Implication | Lag |
|---|---|---|---|---|
| NFLX | iv_spike | implied move ~+/-7.8% to +/-8.9% vs ~5.99% four-quarter avg (into Jul 16 AMC) | uncertain — outsized move priced above historical realized; IV-crush risk after. (Reported after the close: revenue miss, EPS beat; ~-5% after hours.) | Free digest (TipRanks); end-of-day pre-event snapshot, not live tape. |
| AA | iv_spike | implied move ~+/-8.28% (into Jul 16 AMC) | uncertain — rich event premium. | Free digest (TipRanks); lagged, partial coverage. |
| ASML | iv_spike | implied move ~+/-8.36% (Jul 15 AMC print) | uncertain — high premium; semi read-through to TSM/NVDA. | Free digest (TipRanks); lagged. |
| TSLA | iv_spike | implied move ~+/-5.7% (Investing.com) to ~+/-7.6% (TipRanks) into Jul 22 AMC — sources conflict | uncertain — event premium building a week out; elevated. | Free sources disagree on the level; no live tape. |
| UNH | iv_spike | pre-earnings implied ~+/-6.27% (into Jul 16 BMO); resolved as a beat-and-raise | bullish (post-print); IV-crush after. | Free digest (TipRanks); lagged. |
| GE | iv_spike | pre-earnings implied ~+/-5.35% (into Jul 16 BMO) | resolved bearish (beat but sold off ~-4%, sell-the-news). | Free digest (TipRanks); lagged. |
| MU | vol_oi | among the most-active large-cap options tapes on a -6% memory-rout day (magnitude of vol/OI UNVERIFIED) | bearish/uncertain — positioning proxy, not confirmed directional flow. | No contract-level free-tier vol/OI verified; flagged UNVERIFIED. No sweep tape. |
| CBOE_EQUITY | pc_skew | aggregated equity/total put/call 1.66 (Jul 14) -> 1.46 (Jul 15) -> 1.23 (Jul 16), per Convextrade aggregator | Elevated hedging moderating into Jul 16 (contrarian-supportive). Absolute level UNVERIFIED (anomalously high for equity-only P/C — likely a blended/total series); the falling direction is the usable signal. | Free Tier-3 aggregator; could not cross-verify against CBOE's own daily stats. Absolute level UNVERIFIED. |
D · Catalyst Calendar
Upcoming events
| Date | Event | Tickers | IV move |
|---|---|---|---|
| 2026-07-16 | Q2 earnings (AMC) — reported: revenue miss, EPS beat; ~-5% after hours | NFLX | high |
| 2026-07-16 | Q2 earnings — record $40.2B rev, capex raised to $60-64B | TSM | normal |
| 2026-07-16 | Q2 earnings (BMO/mixed) | UNHABTGEPLDUSBCFGISRG | normal |
| 2026-07-16 | Q2 earnings (AMC) | AA | high |
| 2026-07-16 | June Retail Sales (+0.2%), Weekly Jobless Claims (208K), Philadelphia Fed Mfg (41.4); Fed speakers Logan, Schmid | SPX | unknown |
| 2026-07-17 | Q2 earnings (BMO) | TFCRFTRV | normal |
| 2026-07-17 | June Housing Starts/Building Permits, June Industrial Production, prelim July UMich Consumer Sentiment (release UNVERIFIED) | SPX | unknown |
| 2026-07-20 | Q2 earnings (BMO/AMC) | DPZSTLDWRBZIONCCK | unknown |
| 2026-07-21 | Q2 earnings (BMO/AMC) | MMMGMDHRHALDHISCHWGPCIBKREQTWAL | unknown |
| 2026-07-22 | Q2 earnings (AMC) | TSLAGOOGLNOWTXN | high |
| 2026-07-22 | Q2 earnings (BMO) | TPMGEVCMETELPHMNTRS | unknown |
| 2026-07-23 | Q2 earnings (BMO/AMC) | FCXAALNOKHBANINTCNEM | unknown |
E · Trade Ideas
What the data implies
ABTlong · track A
Rationale Q2 beat-and-raise (rev $12.6B +13%, adj EPS $1.31, FY EPS raised to $5.45-$5.60) drove a verified ~+10-12.5% gap; Diagnostics +42% and Devices +9% are durable, not one-off.
Invalidation a close back below the pre-earnings base (full gap fill) would signal the beat was already priced
Risk post-earnings gaps can fade; magnitude conflicted across sources
MUneutral · track A/B
Rationale Track-B HBM super-cycle thesis (Strong Buy, PT ~$1,486, +~599% YTD) collides with a 4-day memory rout and TSMC-capex-driven oversupply fear; a straddle-friendly, not clean-directional, name after a ~6x run.
Invalidation long invalidated by a break of the multi-month uptrend or a 2027 memory-oversupply confirmation; caution invalidated by a fresh HBM demand catalyst
Risk EXTRAORDINARY sourced figures (verified but re-check); parabolic momentum cuts both ways
TSMlong · track B
Rationale Jul 16 record Q2 (rev $40.2B, GM 67.7%) with capex raised to $60-64B and Arizona to ~$100B confirms the AI-infra buildout; the same-day dip on capex-intensity fears is the entry, not the thesis-break. Barclays $470->$625.
Invalidation guidance walk-back, a capex cut, or a Taiwan-geopolitics shock; loss of the primary uptrend
Risk geopolitical tail; capex intensity pressures near-term FCF; ADR
MRVLshort · track B
Rationale AWS custom-silicon concentration into a priced-for-growth multiple; Benchmark cut Buy->Hold and the stock fell ~8-9% on Jul 16 in the AI-capex-slowdown tape — freshest confirming catalyst among semi shorts.
Invalidation a confirmed AWS re-award / custom-silicon expansion, or broad AI-ASIC demand re-acceleration; note sell-side PTs (~$253) remain bullish
Risk consensus still bullish — contested short; single-customer headlines cut both ways
TSLAshort · track B
Rationale Margin quality vs a robotaxi-priced multiple; four straight misses, split ratings (PT ~$425). Deliveries (~480k) already known — the Jul 22 print is about margins.
Invalidation a clean margin beat or a credible robotaxi/FSD monetization update on Jul 22 invalidates the short
Risk binary Jul 22 event; implied move is large; sentiment/positioning can squeeze
NFLXneutral · track A
Rationale Implied ~+/-7.8-8.9% into the Jul 16 AMC print was rich vs ~6% realized — a volatility, not direction, setup. (Post-close: revenue miss / EPS beat, ~-5% after hours — within the implied band.)
Invalidation n/a (volatility stance); a >implied-move gap breaks short-premium structures
Risk direction genuinely uncertain; gap risk beyond the implied move
Methodology & limitations
- No live options tape; all flow/IV/put-call from lagged, partial free tiers (TipRanks, Convextrade, Investing.com). Every options claim carries a data-lag caveat.
- CBOE daily equity put/call for Jul 14-16 not cleanly verifiable; the Convextrade series (1.66->1.46->1.23) is anomalously high for equity-only P/C and its absolute level is UNVERIFIED — only the falling direction is used.
- Jul 16 index/VIX closes are Tier-2 media recaps (ts2.tech, Motley Fool/Yahoo), cross-checked across two sources; not exchange-primary (Tier-1) data.
- Russell 2000 exact close and WTI exact settle are UNVERIFIED (only intraday prints citable).
- Track A rising side returned 9 (not 10): a narrow-weakness/broad-strength tape produced only 9 defensibly-sourced large-cap risers; not padded.
- Several Track A catalysts are UNVERIFIED (PYPL +17.2%, PNR -15.0%, ERIE -11.9%, PGR -9.4%, BLK/CBRE/IVZ/BNY): the price moves are sourced (Trefis) but the specific drivers could not be confirmed this pass — flagged catalyst_unverified.
- Several % magnitudes conflict across free 'top movers' widgets (ABT +10% vs +12.5%; UNH +3.6% vs ~+8%; MU -6% vs -6.3%; GOOGL -3.85% vs -4.43%; TSM small-decline magnitude UNVERIFIED) — the more conservative sourced figure was used and the conflict flagged.
- Most single-name market caps in Track A are UNVERIFIED beyond '>= $10B qualifying'; Track B caps are stockanalysis.com Jul 16 snapshots. IVZ (~$10B) and DKNG (~$12.3B) are borderline and flagged.
- Micron and NVIDIA extraordinary figures (MU ~$963.6B / +~599% YTD; NVDA ~$5.02T) were verified across stockanalysis.com and companiesmarketcap but remain unusual and should be re-verified before sizing.
- Track B estimate-revision 'direction' inferred from analyst PT/rating actions and Zacks ranks, not full institutional revision breadth (paywalled).
- Jul 17 macro releases (housing starts, industrial production, prelim UMich sentiment) and GOOGL/IBM implied moves were not confirmable and are marked UNVERIFIED.
- DEEP_DIVE_WATCHLIST was not supplied, so no organic deep-dive cross-reference could be performed; all in_deep_dive_library flags are false by necessity.
- Composite scores are heuristic and reconstructable from the shown sub-scores and the template weights; they are not backtested.
Not financial advice. Educational/analytical only — generated by Daily Market Pulse template v1 (multi-desk scan, RUN_DATE 2026-07-16). Do your own diligence.